CroíValve Announces Funding from Horizon Europe EIC Accelerator
DUBLIN–(BUSINESS WIRE)–CroíValve, a pioneering medical device company innovating a better way to help more patients suffering from Tricuspid Regurgitation (TR), was awarded funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Programme. Part of the EU’s Horizon Europe 2021-2027 Research... Read More →
InterShunt initiates study of device for heart failure treatment
The first procedure in the US using the device was performed at The Christ Hospital Health Network in Ohio. InterShunt Technologies has initiated the EASE HF2 early feasibility study to assess the InterShunt percutaneous atrial shunt catheter (PAS-C) system, intended... Read More →
Demonstration of Biomechanical Safety When Applying a Flowable Hydrogel Tendon Protector: A Cadaver Study featuring TYBR Health
B3 GEL™ SYSTEM SUPPORTING RESEARCH: What Happens When You “Overapply” Tendon Protection? Surgeons may question their application of tendon protection devices: ” ?” A cadaveric study, carried out in conjunction with researchers at the University of Virginia, has the answer.... Read More →
Breakthrough in Cancer Care: Multi4 Medical’s New Technology Cleared by FDA
Swedish MedTech company Multi4 Medical, chaired by renowned investor Erik Selin, has received FDA clearance for its patended technology for automated cancer treatment. The decision means that Multi4 is now approved for commercial sale in the U.S., the world’s largest... Read More →
HealthpointCapital Acquires ImmersiveTouch, Inc., a Leading Extended Reality Surgical Platform
SAN DIEGO and CHICAGO, June 30, 2025 /PRNewswire/ — HealthpointCapital, the leading private equity firm focused exclusively on musculoskeletal healthcare, today announced the acquisition of a majority stake in ImmersiveTouch, Inc. (“ImmersiveTouch” or the “Company”). ImmersiveTouch‘s ImmersiveView™ platform is a... Read More →
Neurent Medical Announces Expanded Access Following Cigna Policy Update for NEUROMARK®
Effective September 15, CPT 31242 is no longer considered experimental, clearing an important barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, June 30, 2025 /PRNewswire/ — Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced that... Read More →
InterShunt Enrolls First Patient in New Heart Failure Study
Innovative procedure aims to ease symptoms and reduce hospitalizations Newswise — MINNEAPOLIS, June 30, 2025 /PRNewswire/ — InterShunt Technologies, Inc., a medical device company focused on developing minimally invasive treatments for heart failure, has officially kicked off its latest clinical... Read More →
STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation
EINDHOVEN, The Netherlands – June 26, 2025 – STENTiT, a pioneering medical device company, developing a novel class of stents with regenera6ve proper6es, today announced the successful implanta6on of its Resorbable Fibrillated Scaffold (RFS). As part of the VITAL-IT 1... Read More →
Emerging technologies in healthcare, part 7: Lattice Medical
Julien Payen, cofounder and CEO of Lattice Medical, describes the company’s 3D-printed, resorbable breast implant that uses a patient’s own fat to regenerate natural breast tissue after a mastectomy. Lattice Medical has created a 3D-printed, resorbable implant called MATTISSE, designed... Read More →
Amplified Sciences Secures Exclusive Patent License from UCSF for Cutting-Edge Diagnostic Technology
West Lafayette, Ind. (June 23, 2025) – Amplified Sciences announced today that it has secured an exclusive global license to a patent from the University of California, San Francisco (UCSF) that helps enable PanCystPro, the company’s first product offered as... Read More →